APGE CIK: 1974640

Apogee Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY22:
−16.4
FY23:
−74.8
FY24:
−171
FY25:
−227
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−274
FY24:
−300
FY25:
−180
Change from FY22 to FY25
millions USD
FY22:
168
FY23:
315
FY24:
495
FY25:
396
millions USD
FY22:
152
FY23:
−33.3
FY24:
23.5
FY25:
−10.5
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−74.9
FY24:
−172
FY25:
−233

All amounts in millions USD Data source:SEC EDGAR